Given the above mentioned literature data, it can be hypothesized that tumor development (including renal cell carcinoma) as well as the clinical course of the disease depend on the expression level of immune checkpoint molecules, inter alia members of PD-1/PD-L1 axis. Here, PDCD1 is linked to neoplasm.